The Filing Desk

Travere Therapeutics vs Zai Lab

Travere Therapeutics TVTX · Zai Lab ZLAB · Pharmaceuticals

Travere Therapeutics reported revenue of $491 million in fiscal 2025, about the same as Zai Lab's $460 million in fiscal 2025. Travere Therapeutics' revenue grew 110.5% in its latest year, and Zai Lab's grew 15.3%. Travere Therapeutics had an operating margin of -12.8%, against -49.9% at Zai Lab.

Side by side

Travere TherapeuticsZai Lab
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$491M$460M
Revenue growth110.5%15.3%
Revenue growth a year, last 5 years19.9%56.5%
Gross margin97.9%58.6%
Operating margin−12.8%−49.9%
Net margin−5.2%−38.1%
Free cash flow—−$159M
Free cash flow margin—−34.5%
Return on capital——
Net debt to EBITDA——
Dividends and buybacks$0M$0M
Change in diluted share count13.1%10.7%
Last close$48.30$21.92
P/E at the last close——
Insider trades, last 12 monthssold $95.9 millionbought $65,804, sold $11.1 million
Piotroski F-score7 of 9—
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Travere TherapeuticsZai Lab
Operating margin
Percent of revenue
Travere TherapeuticsZai Lab
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Travere TherapeuticsZai Lab

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Travere Therapeutics and Zai Lab pages.